Clinical Trials · NCT07715929

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Name: Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingPhase 4Tirzepatide

Phase: Phase 4
Recruitment status: Not Yet Recruiting
Sponsor: Yunlong Wang
Enrollment: 710
Start date: Sep 2026
Locations: See registry
Primary endpoint: Number of Participants With Recurrence of Atrial Fibrillation, Atrial Flutter, or Atrial Tachycardia

View Tirzepatide compound reference